According to an Allergan conference call, Bimatoprost seems to have failed to show significant results for hair growth from midstage studies.
http://blogs.barrons.com/stockstowatchtoday/2013/05/01/allergans-very-bumpy-day/
or
http://www.bloomberg.com/news/2013-...fter-ceo-says-drug-trial-will-be-delayed.html
http://blogs.barrons.com/stockstowatchtoday/2013/05/01/allergans-very-bumpy-day/
or
http://www.bloomberg.com/news/2013-...fter-ceo-says-drug-trial-will-be-delayed.html